IGFBPI antibody (AA 150-250)
Quick Overview for IGFBPI antibody (AA 150-250) (ABIN6142251)
Target
See all IGFBPI AntibodiesReactivity
Host
Clonality
Conjugate
Application
-
-
Binding Specificity
- AA 150-250
-
Sequence
- ILWDAISTYD GSKALHVTNI KKWKEPCRIE LYRVVESLAK AQETSGEEIS KFYLPNCNKN GFYHSRQCET SMDGEAGLCW CVYPWNGKRI PGSPEIRGDP N
-
Cross-Reactivity
- Human, Mouse, Rat
-
Characteristics
- Polyclonal Antibodies
-
Purification
- Affinity purification
-
Immunogen
- A synthetic peptide corresponding to a sequence within amino acids 150-250 of human IGFBP1 (NP_000587.1).
-
Isotype
- IgG
-
-
-
-
Application Notes
- WB,1:500 - 1:2000
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Buffer
- PBS with 0.02 % sodium azide,50 % glycerol, pH 7.3.
-
Preservative
- Sodium azide
-
Precaution of Use
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Storage
- -20 °C
-
Storage Comment
- Store at -20°C. Avoid freeze / thaw cycles.
-
-
- IGFBPI (Insulin-Like Growth Factor Binding Protein 1 (IGFBPI))
-
Alternative Name
- IGFBP1
-
Background
- This gene is a member of the insulin-like growth factor binding protein (IGFBP) family and encodes a protein with an IGFBP domain and a thyroglobulin type-I domain. The protein binds both insulin-like growth factors (IGFs) I and II and circulates in the plasma. Binding of this protein prolongs the half-life of the IGFs and alters their interaction with cell surface receptors.,IGFBP1,AFBP,IBP1,IGF-BP25,PP12,hIGFBP-1,Signal Transduction,Cell Biology & Developmental Biology,Growth factor,Endocrine & Metabolism,Endocrine and metabolic diseases,Diabetes,Cardiovascular,IGFBP1
-
Molecular Weight
- 27 kDa
-
Gene ID
- 3484
-
UniProt
- P08833
-
Pathways
- Myometrial Relaxation and Contraction, ER-Nucleus Signaling, Growth Factor Binding
Target
-